LISTEN: Obamacare. COBRA. Deductibles. Coinsurance. There’s a lot to figure out when you’re on your own looking for health insurance for the first time. KFF Health News senior contributing editor Elisabeth Rosenthal appeared on WAMU’s “Health Hub” series on Sept. 24 to help young adults find a plan that meets their needs. Many young adults…
Astellas Pharma gets global rights to an Evopoint Biosciences antibody drug conjugate that targets Claudin 18.2. Last year, Astellas’s antibody drug Vyloy became the first FDA-approved therapy for this target. The post Astellas Stays Competitive in Hot Gut Cancer Target, Paying $130M to License Evopoint Drug appeared first on MedCity News.
Section 1115 Medicaid demonstration waivers offer states an avenue to test new approaches in Medicaid that differ from what is required by federal statute. Nearly all states have at least one active Section 1115 waiver and some states have multiple 1115 waivers. This brief explains what Section 1115 waivers are and how they are used,…
By EMILY JOHNSON Being a parent during residency requires one or more of the following: ● Family and/or friends nearby who are willing and able to provide free childcare ● A stay-at-home spouse/co-parent ● A spouse/co-parent who is willing to let their own career to be a distant second…
Riverside Health is reporting an increase in revenue and net margins as a result of adopting Abridge’s ambient AI technology. The tool listens to doctor-patient interactions and generates clinical notes — which not only alleviates physicians’ burnout, but also improves their documentation accuracy. The Virginia-based health system saw a 14% increase in HCC diagnoses documented…
During ViVE26, Verizon’s Robin Goldsmith discusses the future of healthcare from a technology perspective
KFF is tracking the Medicaid provisions in the 2025 federal budget bill, including new Medicaid work and verification requirements and a reduction in the expansion match rate for states that use their own funds to cover undocumented immigrants.
Many pandemic-era flexibilities around Medicare coverage of telehealth are due to expire in December 2024. There is bipartisan support for proposed legislation to extend these provisions for another two years, and Congress is weighing the potential benefits, risks, and costs of permanently expanding Medicare coverage of telehealth services. These FAQs provide answers to key questions…
Alveus Therapeutics’ Phase 2-ready lead drug hits the same two targets as Amgen’s MariTide, but with the potential for a dosing advantage. The startup’s pipeline also includes molecules that could compete with drugs in development by Roche and Novo Nordisk. The post Startup Alveus Therapeutics Emerges With $160M to Shape the Future of Obesity Drugs…